Ronald J. Daniels, Director at BridgeBio Pharma, Inc. (BBIO), sold 11,745 shares at $12.80 ($150K) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Open-market sale of $150k BBIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.